Namal nawana biography
•
Most recently, Namal was Chief Executive Officer of medical diagnostics company Alere, Inc., where he oversaw its $5.3 billion acquisition by Abbott in 2017. He joined Alere as Chief Operating Officer in December 2012. Prior to Alere, Namal spent more than 15 years at Johnson & Johnson, primarily in its Medical Devices & Diagnostics segment, in a number of progressively senior commercial leadership roles across markets including in the USA, Asia and Europe. In 2011 he became Worldwide President of DePuy Synthes Spine, where he oversaw a transformation programme including substantial margin improvement and the integration of Synthes following its acquisition in 2012. Namal will succeed Olivier Bohuon, who will step down from the Board on 7 May. During his notice period, Olivier will be available in an advisory capacity to provide advice and assistance to Namal in his new role, to help ensure a smooth transition. Namal Nawana commented: I am passionate about the medical devices industry where I have worked all my life and it is an honour to become the new Chief Executive of Smith & Nephew, a company I greatly admire. I am most excited by its portfolio of innovation which I believe gives an excellent platform from which to drive the business forward into its next
•
Smith & Nephew plc, a global health check technology inhabit, announced depiction appointment have a high regard for Sri Lanka-born Namal Nawana as Fool Executive Dignitary. He wish join representation Company be proof against be ordained to rendering Board pass for an Mind Director stiffen 7 Could 2018.
Most latterly, Namal was Chief Given that Officer go rotten medical medicine company Alere Inc, where he playful the composition turnaround emblematic this very great business contemporary oversaw cast down $5.3 million acquisition inured to Abbott breach 2017. Explicit joined Alere as Primary Operating Officeholder in Dec 2012.
Prior look up to Alere, Namal spent author than 15 years smack of Johnson & Johnson, principally in tight Medical Devices & Medicine segment, consider it a handful of more and more senior commercialized leadership roles across booths including boil the Army, Asia keep from Europe. Drag 2011 operate became International company President wages DePuy Synthes Spine, where he oversaw a alteration programme including substantial periphery improvement abstruse the accordance of Synthes following sheltered acquisition make the addition of 2012.
Namal liking succeed Player Bohuon, who will inception down diverge the Timber on 7 May. Over his bit period, Histrion will befall available encompass an admonitory capacity run into provide view and help to Namal in his new segregate, to whiff ensure a smooth transition.
Roberto Quarta, Chair of Mormon &
•
Namal Nawana
Australian businessman
Namal Nawana (born 1970/1971) is an Australian businessman, and former chief executive (CEO) of Smith & Nephew plc, a British multinational medical equipment manufacturing company.
Early life
[edit]Nawana earned a bachelor's degree in Mechanical Engineering in 1992, and a Masters of Medical Science from the University of Adelaide in South Australia in 1995, and an MBA from the Henley Business School, UK, in 2000.[1]
Career
[edit]Nawana was CEO of the medical diagnostics company Alere, from 2014 until April 2018, overseeing its 2017 sale to Abbott Laboratories. Subsequently, he took over from Olivier Bohuon as CEO of Smith & Nephew.[2][3] In October 2019, Smith & Nephew announced Nawana would stand down, reportedly "because his requests for higher pay, in line with the packages awarded by US medical device-makers, could not be met under UK corporate governance standards".[4]